ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The COVID-19 pandemic is a major international emergency leading to unprecedented medical, economic and societal challenges. Countries around the globe are facing challenges with diabetes care and are similarly adapting care delivery, with local cultural nuances. People with diabetes suffer disproportionately from acute COVID-19 with higher rates of serious complications and death. In-patient services need specialist support to appropriately manage glycaemia in people with known and undiagnosed diabetes presenting with COVID-19. Due to the restrictions imposed by the pandemic, people with diabetes may suffer longer-term harm caused by inadequate clinical support and less frequent monitoring of their condition and diabetes-related complications. Outpatient management need to be reorganised to maintain remote advice and support services, focusing on proactive care for the highest risk, and using telehealth and digital services for consultations, self-management and remote monitoring, where appropriate. Stratification of patients for face-to-face or remote follow-up should be based on a balanced risk assessment. Public health and national organisations have generally responded rapidly with guidance on care management, but the pandemic has created a tension around prioritisation of communicable vs non-communicable disease. Resulting challenges in clinical decision-making are compounded by a reduced clinical workforce. For many years, increasing diabetes mellitus incidence has been mirrored by rising preventable morbidity and mortality due to complications, yet innovation in service delivery has been slow. While the current focus is on limiting the terrible harm caused by the pandemic, it is possible that a positive lasting legacy of COVID-19 might include accelerated innovation in chronic disease management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clarke, P. M., Gray, A. M., Briggs, A., Farmer, A. J., Fenn, P., Stevens, R. J., Matthews, D. R., Stratton, I. M., Holman, R. R., & on behalf of the UK Prospective Diabetes Study (UKPDS) Group (2004) · Diabetologia · doi:10.1007/s00125-004-1527-z · Cited by 615
Greenwood, D. A., Gee, P. M., Fatkin, K. J., & Peeples, M. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817713506 · Cited by 526
Validation of Smartphone Based Retinal Photography for Diabetic Retinopathy Screening
Rajalakshmi, R., Arulmalar, S., Usha, M., Prathiba, V., Kareemuddin, K. S., Anjana, R. M., & Mohan, V. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138285 · Cited by 173
Cited by
Galindo, R. J., Aleppo, G., Klonoff, D. C., Spanakis, E. K., Agarwal, S., Vellanki, P., Olson, D. E., Umpierrez, G. E., Davis, G. M., & Pasquel, F. J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820932903 · Cited by 155
Self-citationDigital Divide and E-Inclusion as Challenges of the Information Society: Research Review
Zdjelar, R., & Žajdela Hrustek, N. (2021) · Journal of information and organizational sciences · doi:10.31341/jios.45.2.14 · Cited by 14
“The pandemic of Covid-19 has pushed society to change its practices and habits by being even more e-included and adopt e-service [22], [23], [24], [25], [26], [27].”
BackgroundBilic Curcic, I., Cigrovski Berkovic, M., Kizivat, T., Canecki Varzic, S., Smolic, R., & Smolic, M. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.780 · Cited by 2
Metadata
- Authors
- Wake, D. J., Gibb, F. W., Kar, P., Kennon, B., Klonoff, D. C., Rayman, G., Rutter, M. K., Sainsbury, C., & Semple, R. K.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-08-01
- Volume
- 183
- Issue
- 2
- Pages
- G67-G77
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W3033569466
- Cited by
- 71
- References
- 3
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.